DE69940320D1 - Betulinsäurederivate zur inhibierung des krebswach - Google Patents

Betulinsäurederivate zur inhibierung des krebswach

Info

Publication number
DE69940320D1
DE69940320D1 DE69940320T DE69940320T DE69940320D1 DE 69940320 D1 DE69940320 D1 DE 69940320D1 DE 69940320 T DE69940320 T DE 69940320T DE 69940320 T DE69940320 T DE 69940320T DE 69940320 D1 DE69940320 D1 DE 69940320D1
Authority
DE
Germany
Prior art keywords
derivatives
betulinic acid
acid derivatives
wax
inhibiting cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69940320T
Other languages
English (en)
Inventor
Sunder Ramadoss
Mannu Jaggi
Mohammad Jamshed Siddiqui
Achla Behl Khanna
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fresenius Kabi Oncology Ltd
Original Assignee
Dabur Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dabur Pharma Ltd filed Critical Dabur Pharma Ltd
Application granted granted Critical
Publication of DE69940320D1 publication Critical patent/DE69940320D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Otolaryngology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69940320T 1998-11-18 1999-11-17 Betulinsäurederivate zur inhibierung des krebswach Expired - Fee Related DE69940320D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3458DE1998 1998-11-18
PCT/IN1999/000065 WO2000046235A1 (en) 1998-11-18 1999-11-17 Novel betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors

Publications (1)

Publication Number Publication Date
DE69940320D1 true DE69940320D1 (de) 2009-03-05

Family

ID=11092803

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69940320T Expired - Fee Related DE69940320D1 (de) 1998-11-18 1999-11-17 Betulinsäurederivate zur inhibierung des krebswach

Country Status (11)

Country Link
EP (1) EP1131337B1 (de)
JP (1) JP2002536382A (de)
KR (1) KR20010080507A (de)
CN (1) CN1326462A (de)
AT (1) ATE420889T1 (de)
AU (1) AU766599B2 (de)
BR (1) BR9915448A (de)
CA (1) CA2350786C (de)
DE (1) DE69940320D1 (de)
WO (1) WO2000046235A1 (de)
ZA (1) ZA200103616B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869535A (en) 1995-03-21 1999-02-09 The Board Of Trustees Of The University Of Illinois Method and composition for selectively inhibiting melanoma
AU2001284946B2 (en) 2000-08-18 2007-02-01 Advanced Life Sciences Inc. Prodrugs of betulinic acid derivatives for the treatment of cancer and HIV
US6951847B2 (en) 2000-09-29 2005-10-04 Regents Of The University Of Minnesota Methods of treating fungal infections using lupeol
WO2002026761A1 (en) * 2000-09-29 2002-04-04 Regents Of The University Of Minnesota Triterpenes having fungicidal activity against yeast
US6979470B2 (en) * 2001-07-17 2005-12-27 Metaproteomics, Llc Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
ES2319653T3 (es) 2003-02-11 2009-05-11 Novelix Pharmaceuticals, Inc. Medicamento para la inhibicion del crecimiento de tumores.
US20090023698A1 (en) * 2005-03-29 2009-01-22 Krasutsky Pavel A Methods of manufacturing bioactive 3-esters of betulinic aldehyde and betulinic acid
GB0604535D0 (en) 2006-03-07 2006-04-12 Sndv Sprl Betulonic acid derivatives
CZ300722B6 (cs) * 2006-09-27 2009-07-22 Univerzita Karlova v Praze, Prírodovedecká fakulta Zpusob prípravy inkluzního komplexu pentacyklických a tetracyklických terpenoidu a farmaceutického prostredku obsahujícího tento inkluzní komplex, inkluzní komplex pentacyklického nebo tetracyklického terpenoidu a farmaceutický prostredek obsahující
CA2932121A1 (en) * 2007-11-30 2009-06-11 Newlink Genetics Corporation Ido inhibitors
KR101027217B1 (ko) * 2009-03-11 2011-04-06 주식회사 바이오폴리메드 신규한 수용성 베툴린 유도체, 이의 제조방법 및 이를 포함하는 주름 개선용 화장료 조성물
US9067966B2 (en) 2009-07-14 2015-06-30 Hetero Research Foundation, Hetero Drugs Ltd. Lupeol-type triterpene derivatives as antivirals
US8802727B2 (en) 2009-07-14 2014-08-12 Hetero Research Foundation, Hetero Drugs Limited Pharmaceutically acceptable salts of betulinic acid derivatives
WO2014105926A1 (en) 2012-12-31 2014-07-03 Hetero Research Foundation Novel betulinic acid proline derivatives as hiv inhibitors
KR101531821B1 (ko) * 2013-11-27 2015-06-24 주식회사 휴메딕스 페길레이션된 베튤린 유도체를 포함하는 경구 투여용 항암제 조성물
US20170129916A1 (en) 2014-06-26 2017-05-11 Hetero Research Foundation Novel betulinic proline imidazole derivatives as hiv inhibitors
MA40886B1 (fr) 2015-02-09 2020-03-31 Hetero Research Foundation Nouveau triterpénone en c-3 avec des dérivés d'amide inverse en c-28 en tant qu'inhibiteurs du vih
WO2016147099A2 (en) 2015-03-16 2016-09-22 Hetero Research Foundation C-3 novel triterpenone with c-28 amide derivatives as hiv inhibitors
KR101909885B1 (ko) * 2018-05-25 2018-10-19 김예원 살리드로사이드 또는 베툴린을 이용한 뇌수막종 개선용 조성물
US11236122B2 (en) 2018-06-29 2022-02-01 Dfh Therapeutics Triterpene amine derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1415601A (en) * 1973-03-14 1975-11-26 Biorex Laboratories Ltd Dihydrobetulinic acid derivatives
US5869535A (en) * 1995-03-21 1999-02-09 The Board Of Trustees Of The University Of Illinois Method and composition for selectively inhibiting melanoma
US5962527A (en) * 1995-03-21 1999-10-05 The Board Of Trustees Of The University Of Illinois Method and composition for treating cancers
EP0943620B1 (de) * 1998-03-18 2005-11-16 Dabur Pharma Ltd. Betulinsauer Derivate zur Hemmung von Krebswachstum

Also Published As

Publication number Publication date
EP1131337A1 (de) 2001-09-12
EP1131337B1 (de) 2009-01-14
AU3073100A (en) 2000-08-25
AU766599B2 (en) 2003-10-16
WO2000046235A1 (en) 2000-08-10
CN1326462A (zh) 2001-12-12
CA2350786C (en) 2008-08-12
JP2002536382A (ja) 2002-10-29
CA2350786A1 (en) 2000-08-10
ZA200103616B (en) 2002-02-19
KR20010080507A (ko) 2001-08-22
BR9915448A (pt) 2002-01-15
WO2000046235B1 (en) 2000-11-02
ATE420889T1 (de) 2009-01-15

Similar Documents

Publication Publication Date Title
DE69940320D1 (de) Betulinsäurederivate zur inhibierung des krebswach
NL350075I2 (de)
AU2001233726A1 (en) Farnesyl protein transferase inhibitors for treating breast cancer
TW200621779A (en) Process for the manufacture of dihydropteridinones
RS115004A (en) Novel thiophenylglycoside derivatives,methods for production thereof, medicaments comprising said compounds and use thereof
TR200103273T2 (tr) Hemisentetik yöntem ve yeni bileşimler.
TW200633977A (en) Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives
ATE238981T1 (de) Antitumorwirkstoffe
RS19504A (en) Novel compounds and compositions as cathepsin inhibitors
GB0322510D0 (en) Novel compounds
DE60312029D1 (de) Verfahren zur herstellung c-7 substituierter 5-androstene
UA97837C2 (ru) Соединения хинолина для лечения нарушений, которые реагируют на модуляцию рецептора серотонина 5-ht6
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
TR200200494T2 (tr) Yağlı asit sintazı inhibitörleri.
ATE393624T1 (de) Verwendung von sesquiterpene enthaltenden zusammenstellungen zur behandlung von krebs
DE60020130D1 (de) Verfahren zur herstellung 3-amino-gallensaurer derivate
DE60123138D1 (de) Verwendung von progesteronrezeptorhemmern zur behandlung von steroid-resistentem brustkrebs
DK1276722T3 (da) Naphthamidin-urokinaseinhibitorer
NZ336042A (en) Farnesyl transferase inhibitors
HUP0001441A2 (hu) Eljárás 4-aza-androszt-1-én származékokat tartalmazó gyógyszerkészítmények előállítására
DE60143023D1 (de) Tumorhemmende nitroacridin-zusammensetzungen
RS50305B (sr) 4-halogenovani 17-metilen steroidi, postupak njihove proizvodnje i farmaceutski sastavi koji sadrže ova jedinjenja
ATE432933T1 (de) Flavopereirinderivate zur krebstherapie
MXPA03003466A (es) Derivados de piranosido.
ATE344666T1 (de) Pyridin-2-yl-methylamin-derivate zur behandlung von opiatsucht

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee